Artificial Intelligence (AI) in Drug Discovery Market by Offering, By Technology, By Application, By End User and By Region – Global Opportunities & Forecast, 2020-2027
Artificial Intelligence (AI) in Drug Discovery Market by Offering (Software and Services), By Technology (Machine Learning and Other Technologies), By Application (Neurodegenerative Diseases, Immuno-oncology, Cardiovascular Disease, Metabolic Diseases and Other Applications), By End User and By Region – Global Opportunities & Forecast, 2020-2027
Artificial Intelligence (AI) in Drug Discovery Market was accounted at USD 243 Million in 2019 and is estimated to grow at a CAGR of 39.6% during forecast period.
Introduction of the Artificial Intelligence (AI) in Drug Discovery Market Report
The Artificial Intelligence (AI) technology has helped in creating a streamlined, automated approach to drug delivery, find candidate molecules, and predict synthesis routes. AI has become a versatile tool that is being implemented in different stages of drug development, such as identification and validation of drug targets, designing of new drugs, enhancing the R&D efficiency, drug repurposing, aggregating, and analyzing biomedicine information.
To have an edge over the competition by knowing the market dynamics and current trends of “Artificial Intelligence (AI) in Drug Discovery Market,” request for Sample Report here
Market Dynamic
Key Drivers and Emerging Trends
Growing need for AI in drug discovery across various industries in order to regulate the cost of the drug discovery and its development is driving the market growth. With the high demand, the number of partnerships has been increased among cross industries. High adoption rate of cloud-based applications and services are further driving the growth of the market. As per the industry journals, the average novel drug discovery and development cost was estimated to USD 2.6 billion. This is mainly due to the narrow development testing funnel, which minimizes the majority of the candidate therapies with the preclinical and phase-1 trail.
The increasing amount of monumental data generated by the molecule screening processes and the preclinical studies is further surging the adoption of artificial intelligence in the drug delivery space. A large amount of data makes the review of the scientific literature a difficult process. Thus, scientists use AI to boost up the screening process and decrease the time needed for studying and identifying drug molecule interactions and histology data. Moreover, the increasing adoption of AI in the drug delivery space to carry out the standard processes such as data mining and customization capabilities of the AI platforms is opening new doors for the growth of the market. The AI algorithm-based models provide accurate analysis of human physiology response comparatively to animal models. Furthermore, AI-based models also help in minimizing the experimental costs and efficient prediction of cross-species differences.
Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report
Offering – Segment Analysis
Based on the offering, the software segment is predicted to dominate the global AI in Drug Discovery market during the forecast period. The less cost and time to market the drug, low failure rate and a large number of software developers for drug discovery is a major factor that is surging the growth of the segment. Moreover, the accelerating demand for the software among the big pharma & biotech companies and research institutes is further energizing the growth of the segment.
Application – Segment Analysis
On the basis of the application, the neurodegenerative diseases segment is expected to grow at a higher CAGR during the forecast period. The ability of AI to discover drugs for complex conditions and the increasing focus of the leading players on offering AI-based platforms for neurological diseases are the two major drivers that are boosting the demand of the segment in the market.
In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here
Regional – Segment Analysis:
Based on the region, North America predicted to hold the largest market share in the global Artificial Intelligence in Drug Discovery market during the forecast period. This region is one of the fastest and largest growing regional market for AI in drug discovery. Countries such as Canada, Mexico, and US, has adopted AI in drug discovery and development at early stage. The prominent AI technology providers such as Google, IBM, Microsoft, NVIDIA, have a strong presence in the US, which is indirectly surging the growth of the market. Furthermore, the well-established pharmaceuticals sector along with the increased attention on R&D & substantial investment are further driving the growth of the market.
Top Market Players
Various notable players operating in the market include Microsoft Corporation, NVIDIA Corporation, IBM Corporation, Google, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, Benevolentai, and Exscientia, among others.
Key Developments:
-
- In 2020, Atomwise Inc., entered into a partnership with FutuRx, a recognized Israeli-based biotechnology incubator focused on innovative, early-stage therapeutic technologies. This collaboration will serve as the first introduction of Atomwise’s AtomNet platform for AI-based drug discovery to a expanding biotech innovation hub in Israel.
- In 2019, Microsoft Corporation collaborated with Novartis to combine Microsoft AI technology with Novartis’ deep life sciences expertise to address the challenges in the drug development including research, clinical trials, and other processes.
Segments covered in the Report:
The global Artificial Intelligence (AI) in Drug Discovery market has been segmented on the basis of Offering, Technology, Application, End User and key regions. Based on Offering, the market is segmented into Software and Services. Based on Technology, the market is segmented into Machine Learning and Other Technologies. Based on Application, the market is segmented into Neurodegenerative Diseases, Immuno-oncology, Cardiovascular Disease, Metabolic Diseases and Other Applications. Based on End User, the market is segmented into pharmaceutical & biotechnology companies, contract research organizations, and research centers and academic, & government institutes.
For detailed scope of the “Artificial Intelligence (AI) in Drug Discovery Market” report request a Sample Copy of the report
Report Coverage |
Details |
Market Base Year |
2019 |
Market Forecast Period |
2020-2027 |
Market Revenues (2019) |
USD 243 Million |
Base Year & Forecast Units |
Revenues (USD Million) |
Market Segment | By Offering, By Technology, By Application, By End-User, By Region |
Regional Coverage | Asia Pacific, Europe, North America, and RoW |
Companies Profiled | Microsoft Corporation, NVIDIA Corporation, IBM Corporation, Google, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, Benevolentai, and Exscientia, among others; a total of 10 companies covered. |
25% Free Customization Available | We will customize this report up to 25% as a free customization to address our client’s specific requirements |
Market Segmentation
Global Artificial Intelligence (AI) in Drug Discovery Market by Offering
-
- Software
- Services
Global Artificial Intelligence (AI) in Drug Discovery Market by Technology
-
- Machine Learning
- Deep Learning
- Supervised Learning
- Reinforcement Learning
- Unsupervised Learning
- Other Machine Learning Technologies
- Other Technologies
- Machine Learning
Global Artificial Intelligence (AI) in Drug Discovery Market by Application
-
- Immuno-oncology
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Other Applications
Global Artificial Intelligence (AI) in Drug Discovery Market by End User
-
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Research Centers and Academic & Government Institutes
Global Artificial Intelligence (AI) in Drug Discovery Market by Region
-
- North America Artificial Intelligence (AI) in Drug Discovery Market (Option 1: As a part of the free 25% customization)
- North America Artificial Intelligence (AI) in Drug Discovery Market by Offering
- North America Artificial Intelligence (AI) in Drug Discovery Market by Technology
- North America Artificial Intelligence (AI) in Drug Discovery Market by Application
- North America Artificial Intelligence (AI) in Drug Discovery Market by End User
- US Artificial Intelligence (AI) in Drug Discovery Market All-Up
- Canada Artificial Intelligence (AI) in Drug Discovery Market All-Up
- Europe Artificial Intelligence (AI) in Drug Discovery Market (Option 2: As a part of the free 25% customization)
- Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering
- Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology
- Europe Artificial Intelligence (AI) in Drug Discovery Market by Application
- Europe Artificial Intelligence (AI) in Drug Discovery Market by End User
- UK Artificial Intelligence (AI) in Drug Discovery Market All-Up
- Germany Artificial Intelligence (AI) in Drug Discovery Market All-Up
- France Artificial Intelligence (AI) in Drug Discovery Market All-Up
- Spain Artificial Intelligence (AI) in Drug Discovery Market All-Up
- Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market All-Up
- Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market (Option 3: As a part of the free 25% customization)
- Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering
- Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology
- Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Application
- Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by End User
- China Artificial Intelligence (AI) in Drug Discovery Market All-Up
- India Artificial Intelligence (AI) in Drug Discovery Market All-Up
- Japan Artificial Intelligence (AI) in Drug Discovery Market All-Up
- Rest of APAC Artificial Intelligence (AI) in Drug Discovery Market All-Up
- RoW Artificial Intelligence (AI) in Drug Discovery Market (Option 4: As a part of the free 25% customization)
- RoW Artificial Intelligence (AI) in Drug Discovery Market by Offering
- RoW Artificial Intelligence (AI) in Drug Discovery Market by Technology
- RoW Artificial Intelligence (AI) in Drug Discovery Market by Application
- RoW Artificial Intelligence (AI) in Drug Discovery Market by End User
- Brazil Artificial Intelligence (AI) in Drug Discovery Market All-Up
- South Africa Artificial Intelligence (AI) in Drug Discovery Market All-Up
- Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market All-Up
- UAE Artificial Intelligence (AI) in Drug Discovery Market All-Up
- Rest of world (remaining countries of the LAMEA region) Artificial Intelligence (AI) in Drug Discovery Market All-Up
- North America Artificial Intelligence (AI) in Drug Discovery Market (Option 1: As a part of the free 25% customization)
Major Players Operating in the Artificial Intelligence (AI) in Drug Discovery (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)
-
- Microsoft Corporation
- NVIDIA Corporation
- IBM Corporation
- Atomwise, Inc.
- Deep Genomics
- Cloud Pharmaceuticals, Inc.
- Insilico Medicine
- Benevolentai
- Exscientia
Frequently Asked Question About This Report
AI for Drug Discovery Market [ICTHM01A-00-0719]
The various factor driving the Artificial Intelligence (AI) in Drug Discovery market include the increasing number of cross-industry collaboration and partnerships, along with the growing requirement to control drug discovery & development costs, are the two significant factors that are responsible for the growth of global artificial intelligence in drug discovery market.
Top Leading players Microsoft Corporation, NVIDIA Corporation, IBM Corporation, Google, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, Benevolentai, and Exscientia, among others.
Artificial Intelligence (AI) in Drug Discovery Market was accounted at USD 243 Million in 2019 and is estimated to grow at a CAGR of 39.6% during forecast period.
North America region is expected to grow Artificial Intelligence (AI) in Drug Discovery market during the forecast period. This region is one of the fastest and largest growing regional market for AI in drug discovery. Countries such as Canada, Mexico, and US, are the early adopters of AI technology in drug discovery and development.
- Published Date: Feb - 2021
- Report Format: Excel/PPT
- Report Code: ICTHM01A-00-0719
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Artificial Intelligence (AI) in Drug Discovery Market by Offering, By Technology, By Application, By End User and By Region – Global Opportunities & Forecast, 2020-2027
$ 4,499.00 – $ 6,649.00